|
TW530047B
(en)
|
1994-06-08 |
2003-05-01 |
Pfizer |
Corticotropin releasing factor antagonists
|
|
US7067664B1
(en)
|
1995-06-06 |
2006-06-27 |
Pfizer Inc. |
Corticotropin releasing factor antagonists
|
|
US6403599B1
(en)
|
1995-11-08 |
2002-06-11 |
Pfizer Inc |
Corticotropin releasing factor antagonists
|
|
WO1997049706A1
(en)
|
1996-06-25 |
1997-12-31 |
Novartis Ag |
SUBSTITUTED 7-AMINO-PYRROLO[3,2-d]PYRIMIDINES AND THE USE THEREOF
|
|
US5985848A
(en)
|
1997-10-14 |
1999-11-16 |
Albert Einstein College Of Medicine Of Yeshiva University |
Inhibitors of nucleoside metabolism
|
|
TW572758B
(en)
|
1997-12-22 |
2004-01-21 |
Sumitomo Pharma |
Type 2 helper T cell-selective immune response inhibitors comprising purine derivatives
|
|
US6187777B1
(en)
|
1998-02-06 |
2001-02-13 |
Amgen Inc. |
Compounds and methods which modulate feeding behavior and related diseases
|
|
US6232320B1
(en)
|
1998-06-04 |
2001-05-15 |
Abbott Laboratories |
Cell adhesion-inhibiting antiinflammatory compounds
|
|
CZ27399A3
(cs)
|
1999-01-26 |
2000-08-16 |
Ústav Experimentální Botaniky Av Čr |
Substituované dusíkaté heterocyklické deriváty, způsob jejich přípravy, tyto deriváty pro použití jako léčiva, farmaceutická kompozice a kombinovaný farmaceutický přípravek tyto deriváty obsahující a použití těchto derivátů pro výrobu léčiv
|
|
WO2001049688A1
(en)
|
2000-01-07 |
2001-07-12 |
Universitaire Instelling Antwerpen |
Purine derivatives, process for their preparation and use thereof
|
|
AR028385A1
(es)
|
2000-04-28 |
2003-05-07 |
Acadia Pharm Inc |
Agonistas muscarinicos
|
|
GB0114286D0
(en)
|
2001-06-12 |
2001-08-01 |
Hoffmann La Roche |
Nucleoside Derivatives
|
|
BR0211810A
(pt)
*
|
2001-08-09 |
2004-08-24 |
Ono Pharmaceutical Co |
Derivados ácido carboxìlico e agente farmacêutico compreendendo os mesmos como ingrediente ativo
|
|
TW200301251A
(en)
|
2001-12-20 |
2003-07-01 |
Wyeth Corp |
Azaindolylalkylamine derivatives as 5-hydroxytryptamine-6 ligands
|
|
RU2217159C1
(ru)
*
|
2002-03-18 |
2003-11-27 |
ООО "Содарм фарма" |
Раствор для ингаляций фармацевтической композиции глутовент и способ его терапевтического применения
|
|
EP1348707B1
(en)
|
2002-03-28 |
2010-08-25 |
Ustav Experimentalni Botaniky AV CR, v.v.i. (Institute of Experimental Botany Academy of Sciences of the Czech Republic, PRO) |
Pyrazolo[4,3-d]pyrimidines, processes for their preparation and methods for therapy
|
|
AU2003232071A1
(en)
|
2002-05-06 |
2003-11-17 |
Genelabs Technologies, Inc. |
Nucleoside derivatives for treating hepatitis c virus infection
|
|
US6713241B2
(en)
|
2002-08-09 |
2004-03-30 |
Eastman Kodak Company |
Thermally developable emulsions and imaging materials containing binder mixture
|
|
ES2363766T3
(es)
|
2002-08-21 |
2011-08-16 |
Albert Einstein College Of Medicine Of Yeshiva University |
Inhibidores de nucleosidasas y fosforilasas de nucleosidos.
|
|
MXPA05003193A
(es)
|
2002-09-27 |
2005-06-08 |
Sumitomo Pharma |
Compuesto de adenina novedoso y uso del mismo.
|
|
JP2007521296A
(ja)
|
2003-07-01 |
2007-08-02 |
メルク エンド カムパニー インコーポレーテッド |
高眼圧の治療のための眼科用組成物
|
|
US20070161582A1
(en)
|
2003-08-08 |
2007-07-12 |
Dusan Mijikovic |
Pharmaceutical compositions and methods for metabolic modulation
|
|
ES2342069T4
(es)
|
2003-09-05 |
2011-01-26 |
Anadys Pharmaceuticals, Inc. |
Ligandos de tlr7 para el tratamiento de la hepatitis c.
|
|
JP2007508305A
(ja)
|
2003-10-03 |
2007-04-05 |
スリーエム イノベイティブ プロパティズ カンパニー |
ピラゾロピリジンおよびその類似物
|
|
ES2388434T3
(es)
|
2003-11-03 |
2012-10-15 |
Glaxo Group Limited |
Dispositivo de administración de fluido
|
|
JPWO2005092892A1
(ja)
|
2004-03-26 |
2008-02-14 |
大日本住友製薬株式会社 |
８−オキソアデニン化合物
|
|
US8012964B2
(en)
|
2004-03-26 |
2011-09-06 |
Dainippon Sumitomo Pharma Co., Ltd. |
9-substituted 8-oxoadenine compound
|
|
ES2652440T3
(es)
|
2004-04-02 |
2018-02-02 |
OSI Pharmaceuticals, LLC |
Inhibidores de proteína cinasa heterobicíclicos sustituidos con anillo 6,6-bicíclico
|
|
JP2007537296A
(ja)
|
2004-05-14 |
2007-12-20 |
アボット・ラボラトリーズ |
治療薬としてのキナーゼ阻害薬
|
|
US20060029642A1
(en)
|
2004-08-03 |
2006-02-09 |
Dusan Miljkovic |
Methods and compositions for improved chromium complexes
|
|
GB0420719D0
(en)
|
2004-09-17 |
2004-10-20 |
Addex Pharmaceuticals Sa |
Novel allosteric modulators
|
|
EA200702235A1
(ru)
|
2005-05-04 |
2008-04-28 |
Пфайзер Лимитед |
Производные 2-амидо-6-амино-8-оксопурина в качестве модуляторов toll-подобных рецепторов для лечения рака и вирусных инфекций, таких как гепатит с
|
|
NZ540160A
(en)
|
2005-05-20 |
2008-03-28 |
Einstein Coll Med |
Inhibitors of nucleoside phosphorylases
|
|
WO2007013964A1
(en)
|
2005-07-22 |
2007-02-01 |
Sunesis Pharmaceuticals, Inc. |
Pyrazolo pyrimidines useful as aurora kinase inhibitors
|
|
EP1931352B1
(en)
|
2005-08-22 |
2016-04-13 |
The Regents of The University of California |
Tlr agonists
|
|
ATE517883T1
(de)
|
2005-08-25 |
2011-08-15 |
Schering Corp |
Imidazolderivate als funktionelle selektive agonisten des alpha2c-adrenorezeptors
|
|
US8003624B2
(en)
|
2005-08-25 |
2011-08-23 |
Schering Corporation |
Functionally selective ALPHA2C adrenoreceptor agonists
|
|
RS20080128A
(sr)
|
2005-09-02 |
2009-05-06 |
Pfizer Inc., |
1h-imidazopiridini supstituisani hidroksi grupom i postupci za dobijanje
|
|
TW200801003A
(en)
|
2005-09-16 |
2008-01-01 |
Astrazeneca Ab |
Novel compounds
|
|
EP1939198A4
(en)
|
2005-09-22 |
2012-02-15 |
Dainippon Sumitomo Pharma Co |
NEW ADENINE CONNECTION
|
|
US20090099216A1
(en)
|
2005-09-22 |
2009-04-16 |
Astrazeneca Aktiebolag A Corporation Of Sweden |
Novel adenine compound
|
|
TW200745114A
(en)
|
2005-09-22 |
2007-12-16 |
Astrazeneca Ab |
Novel compounds
|
|
WO2007034882A1
(ja)
|
2005-09-22 |
2007-03-29 |
Dainippon Sumitomo Pharma Co., Ltd. |
新規アデニン化合物
|
|
JPWO2007034917A1
(ja)
|
2005-09-22 |
2009-03-26 |
大日本住友製薬株式会社 |
新規なアデニン化合物
|
|
WO2007034817A1
(ja)
|
2005-09-22 |
2007-03-29 |
Dainippon Sumitomo Pharma Co., Ltd. |
新規アデニン化合物
|
|
CN1947717B
(zh)
|
2005-10-14 |
2012-09-26 |
卓敏 |
选择性抑制腺苷酸环化酶1的化合物在制备用于治疗神经性疼痛和炎性疼痛的药物中的应用
|
|
JP2009528989A
(ja)
|
2006-02-17 |
2009-08-13 |
ファイザー・リミテッド |
Ｔｌｒ７変調剤としての３−デアザプリン誘導体
|
|
EP2010505B1
(en)
|
2006-03-28 |
2012-12-05 |
Atir Holding S.A. |
Heterocyclic compounds and uses thereof in the treatment of sexual disorders
|
|
GB0610666D0
(en)
*
|
2006-05-30 |
2006-07-05 |
Glaxo Group Ltd |
Fluid dispenser
|
|
CA2653941C
(en)
|
2006-05-31 |
2013-01-08 |
The Regents Of The University Of California |
Substituted amino purine derivatives and uses thereof
|
|
WO2008004948A1
(en)
|
2006-07-05 |
2008-01-10 |
Astrazeneca Ab |
8-oxoadenine derivatives acting as modulators of tlr7
|
|
WO2008005555A1
(en)
|
2006-07-07 |
2008-01-10 |
Gilead Sciences, Inc. |
Modulators of toll-like receptor 7
|
|
TW200831105A
(en)
|
2006-12-14 |
2008-08-01 |
Astrazeneca Ab |
Novel compounds
|
|
ATE490249T1
(de)
|
2007-02-19 |
2010-12-15 |
Glaxosmithkline Llc |
Purinderivate als immunmodulatoren
|
|
WO2008114006A1
(en)
|
2007-03-19 |
2008-09-25 |
Astrazeneca Ab |
9-substituted-8-oxo-adenine compounds as toll-like receptor (tlr7) modulators
|
|
JP5480637B2
(ja)
|
2007-03-19 |
2014-04-23 |
アストラゼネカ・アクチエボラーグ |
Ｔｏｌｌ様受容体（ｔｌｒ７）モジュレーターとしての９−置換−８−オキソ−アデニン化合物
|
|
WO2008114819A1
(ja)
|
2007-03-20 |
2008-09-25 |
Dainippon Sumitomo Pharma Co., Ltd. |
新規アデニン化合物
|
|
TW200902018A
(en)
|
2007-03-20 |
2009-01-16 |
Dainippon Sumitomo Pharma Co |
Novel adenine compound
|
|
US7928111B2
(en)
|
2007-06-08 |
2011-04-19 |
Senomyx, Inc. |
Compounds including substituted thienopyrimidinone derivatives as ligands for modulating chemosensory receptors
|
|
MX2009013832A
(es)
|
2007-06-29 |
2010-03-10 |
Gilead Sciences Inc |
Derivados de purina y su uso como moduladores del receptor 7 similar a un puente.
|
|
GB0715087D0
(en)
|
2007-08-03 |
2007-09-12 |
Summit Corp Plc |
Drug combinations for the treatment of duchenne muscular dystrophy
|
|
MX2010001650A
(es)
|
2007-08-10 |
2010-08-02 |
Glaxosmithkline Llc |
Entidades quimicas biciclicas que contienen nitrogeno para el tratamiento de infecciones virales.
|
|
PE20091156A1
(es)
|
2007-12-17 |
2009-09-03 |
Astrazeneca Ab |
Sales de (3-{[[3-(6-amino-2-butoxi-8-oxo-7,8-dihidro-9h-purin-9-il)propil](3-morfolin-4-ilpropil)amino]metil}fenil)acetato de metilo
|
|
WO2009151910A2
(en)
|
2008-05-25 |
2009-12-17 |
Wyeth |
Combination product of receptor tyrosine kinase inhibitor and fatty acid synthase inhibitor for treating cancer
|
|
US8946239B2
(en)
|
2008-07-10 |
2015-02-03 |
Duquesne University Of The Holy Spirit |
Substituted pyrrolo, -furano, and cyclopentylpyrimidines having antimitotic and/or antitumor activity and methods of use thereof
|
|
JP5519670B2
(ja)
|
2008-08-11 |
2014-06-11 |
グラクソスミスクライン エルエルシー |
アレルギー性、炎症性及び感染性疾患治療用のプリン誘導体
|
|
US8802684B2
(en)
|
2008-08-11 |
2014-08-12 |
Glaxosmithkline Llc |
Adenine derivatives
|
|
EP2324025A1
(en)
|
2008-08-11 |
2011-05-25 |
Smithkline Beecham Corporation |
Purine derivatives for use in the treatment of allergic, inflammatory and infectious diseases
|
|
UA103195C2
(uk)
|
2008-08-11 |
2013-09-25 |
Глаксосмитклайн Ллк |
Похідні пурину для застосування у лікуванні алергій, запальних та інфекційних захворювань
|
|
KR101616396B1
(ko)
*
|
2008-08-11 |
2016-04-28 |
글락소스미스클라인 엘엘씨 |
신규의 아데닌 유도체
|
|
WO2010018132A1
(en)
|
2008-08-11 |
2010-02-18 |
Smithkline Beecham Corporation |
Compounds
|
|
CN102548999A
(zh)
|
2009-01-20 |
2012-07-04 |
山东轩竹医药科技有限公司 |
含有取代的含氮稠杂环的头孢菌素衍生物
|
|
WO2010111406A2
(en)
|
2009-03-24 |
2010-09-30 |
Myriad Pharmaceuticals, Inc. |
Compounds and therapeutic uses thereof
|
|
EA023536B1
(ru)
|
2009-08-07 |
2016-06-30 |
Глаксосмитклайн Байолоджикалс Са |
Производные оксоаденина, конъюгированные с фосфо- или фосфонолипидами
|
|
US8703754B2
(en)
|
2010-02-10 |
2014-04-22 |
Glaxosmithkline Llc |
6-amino-2-{[(1S)-1-methylbutyl]oxy}-9-[5-(1-piperidinyl)-7,9-dihydro-8H-purin-8-one maleate
|
|
WO2011098451A1
(en)
|
2010-02-10 |
2011-08-18 |
Glaxosmithkline Llc |
Purine derivatives and their pharmaceutical uses
|
|
WO2012009258A2
(en)
|
2010-07-13 |
2012-01-19 |
Edward Roberts |
Peptidomimetic galanin receptor modulators
|
|
US20120171229A1
(en)
|
2010-12-30 |
2012-07-05 |
Selecta Biosciences, Inc. |
Synthetic nanocarriers with reactive groups that release biologically active agents
|
|
WO2012106343A2
(en)
|
2011-02-01 |
2012-08-09 |
The Board Of Trustees Of The University Of Illinois |
Hdac inhibitors and therapeutic methods using the same
|
|
CA2826295C
(en)
|
2011-02-04 |
2020-10-20 |
Duquesne University Of The Holy Spirit |
Bicyclic and tricyclic pyrimidine tyrosine kinase inhibitors with antitubulin activity and methods of treating a patient
|
|
CA2841361A1
(en)
|
2011-07-22 |
2013-01-31 |
Glaxosmithkline Llc |
Composition for the treatment of allergic diseases and inflammatory conditions
|
|
AR092198A1
(es)
|
2012-08-24 |
2015-04-08 |
Glaxosmithkline Llc |
Derivados de pirazolopirimidinas
|
|
CN104780923B
(zh)
|
2012-11-20 |
2017-03-15 |
葛兰素史克有限责任公司 |
干扰素诱导剂化合物
|
|
RU2643371C2
(ru)
|
2012-11-20 |
2018-02-01 |
ГЛАКСОСМИТКЛАЙН ЭлЭлСи |
Новые соединения
|
|
PE20151086A1
(es)
|
2012-11-20 |
2015-08-20 |
Glaxosmithkline Llc |
COMPUESTOS DERIVADOS DE 5H-PIRROLO-[3,2-d]PIRIMIDIN-4-AMINA 2,6,7 TRISUSTITUIDOS O 2,7 DISUSTITUIDOS COMO INDUCTORES DEL INTERFERON HUMANO
|
|
AU2015220888B2
(en)
|
2014-02-20 |
2017-05-18 |
Glaxosmithkline Intellectual Property (No.2) Limited |
Pyrrolo[3,2] pyrimidine derivatives as inducers of human interferon
|